BR0111569A - Agentes antivirais de imidazopiridina e imidazopirimidina - Google Patents

Agentes antivirais de imidazopiridina e imidazopirimidina

Info

Publication number
BR0111569A
BR0111569A BR0111569-3A BR0111569A BR0111569A BR 0111569 A BR0111569 A BR 0111569A BR 0111569 A BR0111569 A BR 0111569A BR 0111569 A BR0111569 A BR 0111569A
Authority
BR
Brazil
Prior art keywords
imidazopyridine
imidazopyrimidine
antiviral agents
treatment
imidazopyrimidine antiviral
Prior art date
Application number
BR0111569-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Kuo-Long Yu
Rita L Civiello
Keith D Combrink
Hatice Belgin Gulgeze
Ny Sin
Xiangdong Wang
Nicholas A Meanwell
Brian Lee Venables
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BR0111569A publication Critical patent/BR0111569A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR0111569-3A 2000-06-13 2001-05-08 Agentes antivirais de imidazopiridina e imidazopirimidina BR0111569A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21144700P 2000-06-13 2000-06-13
US26336301P 2001-01-22 2001-01-22
PCT/US2001/014775 WO2001095910A1 (en) 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents

Publications (1)

Publication Number Publication Date
BR0111569A true BR0111569A (pt) 2003-04-29

Family

ID=26906145

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111569-3A BR0111569A (pt) 2000-06-13 2001-05-08 Agentes antivirais de imidazopiridina e imidazopirimidina

Country Status (20)

Country Link
US (1) US6489338B2 (cg-RX-API-DMAC7.html)
EP (1) EP1311268A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004503501A (cg-RX-API-DMAC7.html)
KR (1) KR20030008151A (cg-RX-API-DMAC7.html)
CN (1) CN1436079A (cg-RX-API-DMAC7.html)
AR (1) AR029128A1 (cg-RX-API-DMAC7.html)
AU (2) AU7290601A (cg-RX-API-DMAC7.html)
BR (1) BR0111569A (cg-RX-API-DMAC7.html)
CA (1) CA2412327A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20024078A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0400766A2 (cg-RX-API-DMAC7.html)
IL (1) IL152889A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02012204A (cg-RX-API-DMAC7.html)
NO (1) NO20025977L (cg-RX-API-DMAC7.html)
NZ (1) NZ523566A (cg-RX-API-DMAC7.html)
PE (1) PE20011348A1 (cg-RX-API-DMAC7.html)
PL (1) PL360290A1 (cg-RX-API-DMAC7.html)
RU (1) RU2003100828A (cg-RX-API-DMAC7.html)
UY (1) UY26758A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001095910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774134B2 (en) * 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
PL369432A1 (en) 2001-12-10 2005-04-18 Bristol-Myers Squibb Company Bis hydrochloride monohydrate salt of rsv fusion inhibitor
WO2004043913A2 (en) * 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
JP2007501251A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤化合物を使用する感染予防
EP1682547B1 (en) 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
CA2551178C (en) 2003-12-24 2012-11-06 Biota Scientific Management Pty Ltd Polycyclic agents for the treatment of respiratory syncytial virus infections
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
KR101238430B1 (ko) 2004-07-27 2013-02-28 길리애드 사이언시즈, 인코포레이티드 이미다조［4,5-ｄ］피리미딘, 그들의 용도 및 제조방법
CA2612264C (en) 2005-06-20 2014-09-23 Tibotec Pharmaceuticals Ltd. Heterocyclylaminoalkyl substituted benzimidazoles
BRPI0612317B8 (pt) 2005-06-20 2021-05-25 Janssen R & D Ireland benzimidazóis 2-substituídos, seu processo de preparação e composição farmacêutica
ATE529424T1 (de) 2005-06-20 2011-11-15 Tibotec Pharm Ltd 1-ää2-amino-3-(substituiertes alkyl)-3h- benzimidazolylümethylü-3-substituierte-1,3- dihydrobenzimidazol-2-one als replikationshemmer des respiratorischen syncytialvirus
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
WO2009084544A1 (ja) * 2007-12-27 2009-07-09 Idemitsu Kosan Co., Ltd. 含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
WO2010103306A1 (en) 2009-03-10 2010-09-16 Astrazeneca Uk Limited Benzimidazole derivatives and their use as antivaral agents
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
JPWO2011115150A1 (ja) * 2010-03-18 2013-07-04 興和株式会社 ベンゾチアジン化合物の製造方法
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
TWI530495B (zh) * 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI515187B (zh) * 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI541241B (zh) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI501967B (zh) * 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
CN103893173B (zh) * 2011-03-23 2016-02-24 上海市第一人民医院 靶向人La蛋白的先导化合物及其在制备抗乙型肝炎病毒的药物中的用途
ES2675583T3 (es) * 2012-06-11 2018-07-11 Ucb Biopharma Sprl Bencimidazoles moduladores de TNF-alfa
KR102092612B1 (ko) * 2012-06-15 2020-03-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 호흡기 합포체 바이러스의 항바이러스제로서의 헤테로사이클로 치환된 1,3-디하이드로-2h-벤즈이미다졸-2-온 유도체
AU2013276521A1 (en) * 2012-06-15 2014-12-04 Janssen Sciences Ireland Uc 1,3 -dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
AU2013276518A1 (en) * 2012-06-15 2014-12-04 Janssen Sciences Ireland Uc 4 - substituted 1, 3 - dihydro - 2H - benzimidazol - 2 - one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
EA201590020A1 (ru) * 2012-06-15 2015-03-31 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Новые производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные бензимидазолами, в качестве противовирусных средств против респираторного синцитиального вируса
EP2909195B1 (en) * 2012-10-16 2017-06-14 Janssen Sciences Ireland UC Rsv antiviral compounds
JP2016145155A (ja) * 2013-04-30 2016-08-12 日本農薬株式会社 フタルアミド誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法
HK1219482A1 (zh) * 2013-10-29 2017-04-07 美迪维尔公司 基於喹唑啉的呼吸道合胞病毒抑制剂
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
WO2017066014A1 (en) * 2015-10-14 2017-04-20 Sunnylife Pharma Inc. Bruton's tyrosine kinase inhibitors
WO2019046364A1 (en) * 2017-08-29 2019-03-07 Emory University INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) REPLICATION AND USES THEREOF
EP4051663B1 (en) 2019-10-30 2024-02-21 Janssen Sciences Ireland Unlimited Company Synthesis of 3-nitro-n-(2,2,2-trifluoroethyl)-4-pyridinamine
CN114630828B (zh) * 2019-10-30 2023-10-31 杨森科学爱尔兰无限公司 一种rsv抑制化合物的合成
US12145933B2 (en) 2020-06-11 2024-11-19 Janssen Sciences Ireland Unlimited Company Hemi (L)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethy)-1,3-dihydro-2H-imidazo[4,5-C]pyridin-2-one and pharmaceutical compositions comprising the same
WO2022184606A1 (en) * 2021-03-01 2022-09-09 Janssen Sciences Ireland Unlimited Company Synthesis of rilematovir
CA3247162A1 (en) * 2022-01-28 2023-08-03 Insilico Medicine Ip Limited Ectunocleotide pyrophosphatase-phosphodiesterase 1 (ENPP1) inhibitors and their uses
WO2025026383A1 (en) * 2023-08-02 2025-02-06 Insilico Medicine Ip Limited Crytsalline forms of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
BR9700939A (pt) 1996-02-13 1998-09-01 American Cyanamid Co Compostos aniônicos contendo traiazina úteis como agentes antivirais
NZ505894A (en) 1998-01-29 2002-12-20 Viropharma Inc Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
WO2000004900A1 (en) 1998-07-20 2000-02-03 Bristol-Myers Squibb Company Substituted benzimidazole antiviral agents
EE04592B1 (et) 1999-06-28 2006-02-15 Janssen Pharmaceutica N.V. Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende valmistamismeetod, kasutamine ja vaheühendid, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt

Also Published As

Publication number Publication date
MXPA02012204A (es) 2003-10-15
US6489338B2 (en) 2002-12-03
HUP0400766A2 (hu) 2004-07-28
NO20025977L (no) 2003-01-29
JP2004503501A (ja) 2004-02-05
PE20011348A1 (es) 2002-02-07
AU7290601A (en) 2001-12-24
KR20030008151A (ko) 2003-01-24
CZ20024078A3 (cs) 2003-08-13
EP1311268A1 (en) 2003-05-21
CA2412327A1 (en) 2001-12-20
WO2001095910A1 (en) 2001-12-20
IL152889A0 (en) 2003-06-24
NZ523566A (en) 2004-08-27
NO20025977D0 (no) 2002-12-12
RU2003100828A (ru) 2004-06-27
UY26758A1 (es) 2002-01-31
EP1311268A4 (en) 2004-06-30
CN1436079A (zh) 2003-08-13
AU2001272906B2 (en) 2004-08-26
AR029128A1 (es) 2003-06-04
PL360290A1 (en) 2004-09-06
US20020016309A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
BR0111569A (pt) Agentes antivirais de imidazopiridina e imidazopirimidina
WO2002062290A3 (en) Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
WO2003053344A3 (en) Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
AU2134402A (en) Antiviral agents
NZ515392A (en) Respiratory syncytial virus replication inhibitors
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
WO2002088124A3 (en) Pyrazolo'1,5-a!pyridine derivatives
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
BR0210350A (pt) Nucleosìdeos 4'-substituìdos
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
BR0207172A (pt) Pirido-pirimidinas 6-substituìdas
ATE135365T1 (de) Antivirale verbindungen
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
DE69829175D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
BR0211289A (pt) Derivados de dolastatina 10
BRPI0507675A (pt) derivados de 2'-c-metil nucleosìdeo
IL158667A0 (en) Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections
BR0212069A (pt) Agentes antidiabéticos orais
BR0100155A (pt) Azabenzimidazóis aril substituìdos e sua utilização no tratamento de hiv e doenças relacionadas com aids
BR0215016A (pt) Piridoquinoxalinas antivirìcas
NZ505894A (en) Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
BRPI0406673A (pt) Método para o tratamento ou profilaxia e composição para uso no tratamento ou profilaxia de um ou mais sintomas de uma infecção por herpes viral em um indivìduo, e, uso de uma composição compreendendo um sal citrato e/ou um succinato
DE602005018972D1 (de) 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren
WO2002072581A3 (en) Pyrazolopyriadine derivatives
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009.